Zhejiang Jianfeng Group Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Jianfeng Group Company Limited with three other
companies in this sector in China:
ChangChun High New Technology Industries
sales of 2.37 billion Chinese Renmimbi [US$345.02 million]
of which 79%
Shenzhen Hepalink Pharmaceutical Company Limited
(2.29 billion Chinese Renmimbi [US$332.66 million]
of which 100%
was Pharmaceutical Manufacturing), and
Shanxi Zhendong Pharmaceutical Co Ltd
(2.26 billion Chinese Renmimbi [US$328.64 million]
of which 95%
was Medicine Manufacture and Sale).
Zhejiang Jianfeng Group Company Limited reported sales of 2.26 billion Chinese Renmimbi (US$328.03 million)
December of 2015.
a very small
increase of 0.1%
versus 2014, when the company's sales were 2.26 billion Chinese Renmimbi.
Sales at Zhejiang Jianfeng Group Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 70%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
8.7% in 2015, from
189.38 million Chinese Renmimbi to 205.89 million Chinese Renmimbi.
Not all segments of Zhejiang Jianfeng Group Company Limited experienced an increase in sales in 2015:
sales of Other Operation fell 16.1% to 15.15 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Zhejiang Jianfeng Group Company Limited also experienced decreases in sales in
Pharmaceutical (down 2.0% to 1.01 billion Chinese Renmimbi)
Cement/construction Materials (down 12.9% to 891.44 million Chinese Renmimbi)